The pill, known as Paxlovid, has been approved after it was found to be" safe and effective" at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 infection. This follows a rigorous review of its safety, quality and effectiveness by the UK regulator and expert advice from the government’s independent scientific advisory body, the Commission on Human Medicines. Developed by Pfizer, Paxlovid is an antiviral medicine with a combination of active ingredients, PF-
综合
每日快报-科学
2021-12-31 00:00:00.0